Interleukin-2 (IL-2) inhibitors are immunosuppressive agents that block the activity of IL-2, a cytokine involved in the activation and proliferation ...

Early intervention with IL-17 inhibitors among patients with plaque psoriasis is associated with improved relapse and remission rates.

Interleukin Inhibitors Stelara , also known as ustekinumab, is a monoclonal antibody that targets specific proteins called interleukin-12 (IL-12) and interleukin-23 (IL-23).

Access free, up-to-date clinical references for treating Rheumatoid Arthritis with Interleukin-6 Inhibitors at Healio. Our content provides valuable insights for physicians.

Researchers think there may be a better coronavirus cure than remdesivir and dexamethasone for severe COVID-19 cases that can lead to complications and death. A … ...

The interleukin-17 inhibitors market is expected to remain strong in rheumatology (psoriasis and arthritis), with potential expansion into hidradenitis suppurativa and other dermatologic conditions.

New research from Boston Medical Center found that patients experiencing severe COVID-19 symptoms had improved outcomes when administered an Interleukin-6 (IL6ri) inhibitor, sarilumab or ...

During the pandemic, healthcare professionals have been using immune-modifying drugs called interleukin-6 (IL-6) receptor inhibitors “off label” in an attempt to prevent this from happening.

Interleukin-1 inhibitors are associated with a “significant reduction” in mortality among patients hospitalized with COVID-19, respiratory insufficiency and hyperinflammation, according ...

Thus far, randomized, controlled trials have shown that treatment with glucocorticoids, Janus kinase inhibitors, and perhaps interleukin-6 receptor antagonists reduces mortality among patients ...

A study found low rates of cancer recurrence, progression, or new malignancy among patients with psoriasis and prior neoplasia receiving interleukin-23 (IL-23) inhibitors. Researchers conducted a ...